Your browser is no longer supported. Please, upgrade your browser.
Settings
ATXI [NASD]
Avenue Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.23 Insider Own0.40% Shs Outstand16.63M Perf Week18.02%
Market Cap25.34M Forward P/E- EPS next Y-0.19 Insider Trans-8.47% Shs Float8.59M Perf Month-19.14%
Income-3.80M PEG- EPS next Q-0.05 Inst Own5.80% Short Float1.57% Perf Quarter-24.71%
Sales- P/S- EPS this Y81.10% Inst Trans-5.16% Short Ratio0.33 Perf Half Y-70.76%
Book/sh-0.01 P/B- EPS next Y4.30% ROA-215.70% Target Price- Perf Year-60.90%
Cash/sh0.03 P/C42.23 EPS next 5Y- ROE-353.20% 52W Range1.02 - 7.69 Perf YTD-77.98%
Dividend- P/FCF- EPS past 5Y13.00% ROI- 52W High-82.96% Beta0.68
Dividend %- Quick Ratio0.80 Sales past 5Y- Gross Margin- 52W Low28.43% ATR0.17
Employees4 Current Ratio0.80 Sales Q/Q- Oper. Margin- RSI (14)47.63 Volatility22.86% 12.36%
OptionableNo Debt/Eq- EPS Q/Q15.80% Profit Margin- Rel Volume0.60 Prev Close1.26
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume402.75K Price1.31
Recom3.00 SMA20-4.86% SMA50-7.41% SMA200-58.18% Volume243,057 Change3.97%
Nov-29-21 08:00AM  
Nov-17-21 09:30AM  
Nov-12-21 10:40AM  
09:20AM  
Nov-09-21 09:30PM  
Oct-25-21 07:00AM  
Aug-26-21 11:04AM  
Jun-21-21 08:04AM  
Jun-14-21 08:42AM  
07:44AM  
07:00AM  
Apr-26-21 08:09AM  
Apr-23-21 11:36PM  
09:43AM  
08:41AM  
Apr-22-21 10:59AM  
Apr-21-21 10:34PM  
09:38AM  
Apr-19-21 10:09PM  
06:26AM  
Apr-16-21 11:25PM  
Apr-14-21 10:34PM  
Apr-13-21 11:30PM  
03:09PM  
02:30PM  
09:33AM  
06:30AM  
Apr-12-21 01:36AM  
Jan-11-21 11:32PM  
Jan-06-21 09:23AM  
Dec-18-20 08:00AM  
08:00AM  
Dec-17-20 04:27PM  
07:00AM  
Nov-13-20 05:28AM  
Oct-28-20 07:45PM  
Oct-23-20 10:00PM  
Oct-14-20 08:58PM  
10:10AM  
Oct-13-20 01:29PM  
Oct-12-20 01:35PM  
12:45PM  
10:47AM  
06:30AM  
Sep-09-20 08:00AM  
Aug-17-20 10:33AM  
Aug-14-20 07:30AM  
Aug-04-20 12:53PM  
Jul-28-20 05:50PM  
Jul-22-20 05:50PM  
Jul-21-20 08:30AM  
Jul-16-20 05:50PM  
Jul-09-20 05:50PM  
11:30AM  
Jul-07-20 11:50AM  
Jun-29-20 08:30AM  
Jun-25-20 08:44AM  
Jun-24-20 12:00PM  
11:18AM  
Jun-23-20 10:38AM  
Jun-18-20 10:12AM  
08:50AM  
Jun-17-20 11:30AM  
Jun-16-20 08:37AM  
Jun-15-20 10:00AM  
Jun-11-20 08:55AM  
08:41AM  
Jun-10-20 08:31AM  
Jun-09-20 09:41AM  
Jun-08-20 08:25AM  
Jun-05-20 08:30AM  
May-29-20 11:33AM  
10:31AM  
08:30AM  
May-28-20 09:13AM  
May-27-20 12:43PM  
11:30AM  
09:40AM  
May-26-20 10:44AM  
10:43AM  
08:54AM  
May-22-20 08:42AM  
06:50AM  
May-11-20 07:30AM  
Apr-27-20 09:48AM  
Apr-24-20 11:07AM  
Apr-23-20 09:14AM  
08:30AM  
07:25AM  
Apr-16-20 12:00PM  
Mar-30-20 07:30AM  
Feb-13-20 08:00AM  
Dec-13-19 08:10AM  
Dec-11-19 08:30AM  
Nov-04-19 07:30AM  
Oct-28-19 08:30AM  
Oct-18-19 08:30AM  
Aug-14-19 07:30AM  
Aug-01-19 08:00AM  
Jun-07-19 01:51PM  
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, which is in Phase III clinical trials to treat moderate to moderately severe post-operative pain. The company was incorporated in 2015 and is based in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vazzano Joseph WalterChief Financial OfficerSep 15Sale1.627,16011,59965,252Sep 15 04:03 PM
Herskowitz NeilDirectorMay 06Buy3.992,5009,975134,724May 07 08:02 AM